AnalystsLeland GershellLeland Gershell's Stock Forecasts
AnalystsLeland Gershell
Analyst Ranking
Top 10%
#449 out of 4595 analysts
Average Return
+21.47%
Win Rate
30%24 out of 79
Risk vs Reward
Poor
Good
Leland Gershell's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Soleno Therapeutics IncSLNO | +1,687.66% | $2.35 | $42.01 | 2023-03-24 - 2024-03-22 | Buy |
Soleno Therapeutics IncSLNO | +758.78% | $4.90 | $42.08 | 2023-09-15 - 2024-05-31 | Buy |
Soleno Therapeutics IncSLNO | +718.29% | $5.03 | $41.16 | 2023-05-25 - 2024-05-24 | Buy |
Crinetics Pharmaceuticals IncCRNX | +156.41% | $17.32 | $44.41 | 2023-08-31 - 2024-05-31 | Buy |
X4 Pharmaceuticals IncXFOR | +73.81% | $0.84 | $1.46 | 2023-03-24 - 2024-03-22 | Buy |
Leland Gershell Analyst Color
Get additional color on Leland Gershell's coverage of popular stocks
Leland Gershell's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | 1 | Buy | $14.00 | +146.48% | Initiates Coverage On | 17 days ago |
Essa Pharma IncEPIX | 1 | Buy | $17.00 | +151.85% | Maintains | 18 days ago |
Urogen Pharma LtdURGN | 6 | Buy | $32.00 | +140.60% | Maintains | 20 days ago |
Soleno Therapeutics IncSLNO | 6 | Buy | $59.00 | +40.21% | Maintains | 21 days ago |
Viridian Therapeutics IncVRDN | 4 | Buy | $31.00 | +159.41% | Maintains | 24 days ago |
Protara Therapeutics IncTARA | 2 | Buy | $30.00 | +967.62% | Maintains | a month ago |
Avalo Therapeutics IncAVTX | 1 | Buy | $35.00 | +199.53% | Upgrades | 2 months ago |
Veru IncVERU | 5 | Buy | $5.00 | +395.05% | Reiterates | 2 months ago |
Cue Biopharma IncCUE | 1 | Buy | $10.00 | +513.50% | Maintains | 2 months ago |
Nucana PLCNCNA | 5 | Buy | $100.00 | +2,670.08% | Reiterates | 2 months ago |
Calcimedica IncCALC | 4 | Buy | $14.00 | +146.48% | Maintains | 2 months ago |
Xeris Biopharma Holdings IncXERS | 1 | Buy | $5.00 | +121.73% | Initiates Coverage On | 2 months ago |
Immunovant IncIMVT | 1 | Buy | $50.00 | +96.93% | Initiates Coverage On | 2 months ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Buy | $29.00 | +79.34% | Reiterates | 2 months ago |
Trevi Therapeutics IncTRVI | 2 | Buy | $9.00 | +250.19% | Maintains | 2 months ago |
Crinetics Pharmaceuticals IncCRNX | 5 | Buy | $55.00 | +23.85% | Maintains | 2 months ago |
Lumos Pharma IncLUMO | 4 | Buy | $16.00 | +611.11% | Maintains | 3 months ago |
Pds Biotechnology CorpPDSB | 3 | Buy | $20.00 | +571.14% | Maintains | 7 months ago |
Milestone Pharmaceuticals IncMIST | 3 | Buy | $13.00 | N/A | Maintains | a year ago |
X4 Pharmaceuticals IncXFOR | 1 | Buy | $4.00 | N/A | Maintains | a year ago |
Alnylam Pharmaceuticals IncALNY | 4 | Buy | $249.00 | N/A | Maintains | a year ago |
Biomarin Pharmaceutical IncBMRN | 1 | Buy | $110.00 | N/A | Upgrades | 2 years ago |
Argenx SeARGX | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Clene IncCLNN | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Plx Pharma IncPLXPQ | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Ascendis Pharma AASND | 5 | Buy | $144.00 | N/A | Maintains | 2 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Buy | $140.00 | N/A | Initiates Coverage On | 2 years ago |
Acasti Pharma IncACST | 3 | Buy | $36.00 | N/A | Initiates Coverage On | 2 years ago |
Opiant Pharmaceuticals IncOPNT | 1 | Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Windtree Therapeutics IncWINT | 1 | Buy | $7,200.00 | N/A | Initiates Coverage On | 3 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Casi Pharmaceuticals IncCASI | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Vaccinex IncVCNX | 2 | Buy | $1,470.00 | N/A | Maintains | 4 years ago |
Fresh Tracks Therapeutics IncFRTX | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 4 years ago |
Acceleron Pharma IncXLRN | 1 | Buy | $112.00 | N/A | Maintains | 4 years ago |
Epizyme IncEPZM | 1 | Hold | $16.00 | N/A | Downgrades | 4 years ago |
Amarin Corp PLCAMRN | 1 | Hold | N/A | N/A | Upgrades | 4 years ago |
Trevena IncTRVN | 1 | Buy | $325.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.